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Aims: Obstructive symptoms such as slow stream, dribbling and straining are often reported by painful bladder
syndrome and interstitial cystitis (PBS/IC) patients. Our hypothesis was that some patients with PBS/IC have an
associated measurable bladder outlet obstruction (BOO) secondary to dysfunctional voiding and that those patients
with more severe PBS/IC are more likely to have BOO. Methods: This is a retrospective chart review of female
patients diagnosed with PBS/IC based on the NIDDK research definition. Charts were reviewed for clinical
symptom severity, ulcer or non-ulcer PBS/IC on cystoscopy, and pressure-flow urodynamics (UDPF). Patients were
excluded if they had a urinary infection at the time of urodynamics or did not meet study entry requirements. The
cut-off values of 12 ml/sec and 25 cm of water was used to define BOO. Results: Of the 231 women: 38 had ulcer
PBS/IC and 193 had non-ulcer PBS/IC. MCC was 269 ml in non-ulcer PBS/IC and 200 ml in ulcer PBS/IC
(P ¼ 0.006). One hundred eleven women (48%) met criteria for obstruction. MCC was 298 ml in the non-obstructed
group and 214 ml in the obstructed group (P < 0.0001). The maximum flow with non-ulcer PBS/IC was 11.0 ml/sec
and in ulcer PBS/IC 8.9 ml/sec (P ¼ 0.04) Detrusor pressure at maximum flow was 33.3 cm H2O, in non-ulcer, and
37.4 cm H2O in ulcer PBS/IC (P ¼ 0.01). Conclusions: Forty-eight percent of our PBS/IC patients have BOO, and
increasing severity of PBS/IC is associated with higher voiding pressure. Neurourol. Urodynam. 28:944–948,
2009.  2009 Wiley-Liss, Inc.
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INTRODUCTION
Painful bladder syndrome (PBS) is defined by the Interna-
tional Continence Society as ‘‘the complaint of suprapubic
pain related to bladder filling, accompanied by other symp-
toms such as increased day- and night-time frequency, in the
absence of proven urinary infection or other obvious pathol-
ogy’’ and the diagnosis of interstitial cystitis (IC) is reserved for
those who have ‘‘typical cystoscopic and histologic features’’.1
It is a common entity with the prevalence of PBS symptoms
reported as frequently as 0.83–2.71% in women.2
PBS/IC is a chronic disease that is very difficult to treat. Life
style modifications, oral medications, hydrodistension, intra-
vesical treatment, sacral nerve modulation, and surgical
treatment have all been attempted with varying degrees of
success.3 In our experience, some women with PBS/IC also
complain of symptoms of voiding dysfunction including
bladder outlet obstruction (BOO). They have a sensation of
incomplete emptying, slow stream, straining to void, and
dribbling. There is little data in the literature on urodynamic
pressure-flow (UDPF) studies in PBS/IC patients. Recently,
several authors have published pressure-flow criteria to
diagnose female BOO.4–10 In our patient population we have
a significant number of PBS/IC patients who have undergone
UDPF and with these criteria there existed an opportunity
to assess our patient population with PBS/IC for possible
obstruction. We hypothesized that some patients with PBS/IC
had an associated measurable BOO and that those patients
with the more severe ulcer variant of PBS/IC were more likely
to have BOO and worse urinary symptoms.
MATERIALS AND METHODS
After institutional review board approval all of our PBS/IC
patient population had their charts retrospectively reviewed.
Two hundred seventy-four patients who met the National
Institute of Diabetes, Digestive and Kidney Disease (NIDDK)
research definition of IC,11 had completed pressure-flow
urodynamic studies (UDPF), a urinary symptom score
(Table I) and had a cystoscopy with hydrodistention from
May 1996 to June 2004 were included (Appendix A). It was
routine practice at that time to perform urodynamics and
cystoscopic hydrodistention under general anesthetic on all
women with suprapubic pain and lower urinary tract
symptoms. Any woman with missing data (18 patients) or a
urinary tract infection at the time of UDPF (5 patients) was
excluded. Twenty patients were excluded because their
urodynamic studies could not be interpreted since they could
not void during the study. Patients were also excluded if they
did not meet NIDDK research definition, except for the
presence of detrusor instability, which we did not consider
an exclusion criterion.12 Information collected included past
medical history, gynecological or urologic surgery, history of
stones or UTI, neurologic disease, parity, age, and incon-
tinence.
The symptom score was collected verbally by the examiner
and included questions regarding frequency, urgency, noctu-
ria, and suprapubic pain. Scores were calculated based on our
grading system (Table I).
A physical examination was also performed specifically
noting the presence of suprapubic pain on palpation. All
patients had a cystoscopic examination under general
Conflict of interest: none.
Dirk De Ridder led the review process.
*Correspondence to: Anne P. Cameron, MD, 1500 E Medical Center Drive, 3875
Taubman Center, Ann Arbor, MI 48109. E-mail: annepell@med.umich.edu
Received 28 November 2008; Accepted 18 February 2009
Published online 19 March 2009 in Wiley InterScience
(www.interscience.wiley.com)
DOI 10.1002/nau.20729
 2009 Wiley-Liss, Inc.
anesthetic and had bladder hydrodistention performed at
80 cm water pressure for a minimum of 60 sec. The bladder
was then drained and re-examined for glomerulations. These
were present in all cases and PBS/IC was classified as either
ulcer (classic) or non-ulcer (non-classic) based on cystoscopic
appearance.13
After non-invasive uroflowmetry UDPF study was done in a
standardized fashion in a semi-sitting position with a double
lumen #7 F urodynamics catheter in the bladder and a rectal
balloon catheter to measure abdominal pressure. Bladder
filling was performed at 50 ml/min with room temperature,
sterile normal saline as the filling solution. All patients had
both cystometry and pressure-flow studies. Patients were
asked to void when they were comfortably full and this
volume was recorded as the maximum cystometric capacity
(MCC). Electromyography was performed using patch electro-
des on the perianal area to assess pelvic floor relaxation.
A single filling and voiding study was performed with a
leak point pressure performed before voiding in the sitting
position. Urodynamic studies were each interpreted inde-
pendently by both authors and discrepancies in interpretation
discussed and a consensus obtained. The cut-off values of
maximum flow rate (Qmax) 12 ml/sec and detrusor pressure
at maximum flow (PdetQmax) 25 cm H2O were used to define
BOO in these women.6 Urodynamic data collected included
Qmax, PdetQmax, MCC, voided volume, and post void residual
(PVR).
Urinary tract symptom severity was compared between
the ulcer and non-ulcer cystoscopic appearance of PBS/IC and
between those with BOO on UDPF and those without. For
group comparison unpaired t-test, Mann–Whitney test, and
Chi-square analysis were used. P-values of less than 0.05 were
considered statistically significant.
RESULTS
There were 231 women with a mean age of 52.4  13.7 years
who were included in the study. One hundred ninety-three
(83.5%) had non-ulcer IC/PBS and 38 (16.5%) had the ulcer
variant. These groups were not different with respect to age,
past medical history or surgical history except for hyster-
ectomy, which was more common in the non-ulcer group 10/
38 versus 93/193 (P ¼ 0.02; Table II). On the individual urinary
symptom questions, these groups were not different with
respect to reported urinary frequency, urgency, nocturia or
suprapubic pain, and the symptoms score sum was also not
different (Table III). MCC was 269 ml in non-ulcer PBS/IC and
200 ml in ulcer variant (P ¼ 0.006). Detrusor pressure at
maximum flow was not significantly different between these
two groups, but maximum flow was 11.0 ml/sec in non-ulcer
and 8.9 ml/sec in ulcer PBS/IC (P ¼ 0.04). The occurrence of
detrusor overactivity on UDPF studies was not different
between these two groups nor was the finding of suprapubic
pain on physical examination. Mean PVR was 77.4 ml in
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TABLE I. Symptoms Score
Symptoms 0 1 2 3
Frequency >q2h q2h q1–2h <q1h
Nocturia 0–1 2 3–4 5
Suprapubic pain None Mild Moderate Severe
Urgency None 1/week 1/day Always











Age 53.1  13.9 49.8  13.1 0.2 53.1  13.3 51.6  14.1 0.4
Medical history
IHD 8 0 0.4 4 4 0.7
High cholesterol 19 1 0.2 13 7 0.2
Thyroid disease 24 1 0.09 14 11 0.8
Psychiatric disorder 17 1 0.3 9 9 1.0
Arthritis 34 3 0.2 16 21 0.2
Hypertension 42 6 0.5 22 25 0.5
Asthma 28 2 0.2 11 19 0.08
Bronchitis 19 3 1.0 8 14 0.2
Stroke 2 2 0.1 2 2 1.0
Diabetes 15 0 0.1 6 9 0.4
Diverticulitis 6 0 0.6 3 3 1.0
Endometriosis 3 1 0.5 1 3 0.4
Stone disease 3 1 0.5 2 2 1.0
UTIs 2 2 0.1 2 2 1.0
Surgical history
Hysterectomy 93 10 0.02 58 46 0.4
Oophrectomy
alone
9 1 0.5 3 7 0.2
Tubal ligation 29 4 0.6 18 15 0.9
Anterior repair 7 1 1.0 4 4 1.0
Bladder suspension 40 4 0.2 22 22 0.9
Pregnancy
G 2.8  1.9 2.7  1.4 0.8 2.9  1.8 2.7  1.8 0.7
P 2.6  1.7 2.7  1.3 0.8 2.6  1.7 2.6  1.7 0.9
Chi square analysis performed on all results.
IH, dischemic heart disease; UTIs, urinary tract infections; G, gravida; P, para.
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non-ulcer and 56.2 ml in ulcer disease, but this difference was
not significant (Table IV).
Of the 231 women, 111 (48.1%) were found to have
urodynamic obstruction based on the cut-off values of Qmax
12 ml/sec and PdetQmax 25 cm H2O.6 46.6% of these women
had non-ulcer PBS/IC and 55.2% had the ulcer variant, but the
difference between these two groups did not reach statistical
significance (P ¼ 0.7) (Fig. 1).
When comparing those with obstruction and those with-
out, there was no statistical difference in age, past medical or
surgical history (Table II). Individual urinary symptom scores
were not significantly different between the groups except for
urinary frequency, which was worse in the obstructed group
and the score sum was significantly higher in the obstructed
group (Table III). As expected, urodynamic parameters were
very different in the two groups. Mean MCC was 214 ml in the
obstructed group and 298 ml in the non-obstructed women
(P < 0.0001). Also PVR was much higher in the obstructed
group at 91.0 ml than 58.2 ml in the non-obstructed group
(P ¼ 0.006) (Table IV).
EMG data were unfortunately not sufficient for statistical
analysis.
DISCUSSION
In this analysis 48.1% of women with an NIDDK research
definition of IC had evidence of obstruction on pressure-flow
urodynamics. This obstruction, we believe, is due to dysfunc-
tional voiding and not stricture disease or other anatomical
obstruction since none of these women had obstruction seen
on cystoscopy and urodynamic catheterization was not
difficult in any case. Also, there was no statistical difference
in the number of anti-incontinence procedures in the
obstructed group compared to the non-obstructed group
(Table II). The women with ulcer PBS/IC had smaller MCC
and slower maximum flows compared to those with the non-
ulcer variety. The finding of more urodynamic obstruction in
this ulcer PBS/IC group is not surprising since they have the
more severe variant of the disease, which may cause the pelvic
floor to be less able to relax during voiding because of more
severe pain. This coincides with our initial hypothesis that the
more severe ulcer variant of PBS/IC would have a greater
likelihood of BOO, unfortunately the number of women who
met the obstruction criteria that we selected was not different
between the groups.
We had postulated that painful voiding was at the root of
the problem with pain causing reflexive poor pelvic floor
relaxation. The concept of bladder pain causing outlet
obstruction is not new. Webster studied 152 women with
recurrent cystitis with pressure-flow videourodynamic studies
and found that a third were actually obstructed, with the
obstruction seen at the area of external sphincter. He proposed
that the external sphincter was in spasm in response to a
nearby inflammation and that these spasms should normally
abates, but with chronic inflammation a vicious cycle is set up
with persistent outflow obstruction.14 In a different study
evaluating the pelvic floor of 70 women with IC, 87% were
found to have levator pain consistent with pelvic floor
dysfunction.15 Other authors agree with the hypothesis that
external sphincter spasticity syndrome16–18 or failure of pelvic
floor relaxation17,19 can arise from inflammatory conditions or
pain in the lower urinary tract.
Bladder symptoms that define IC/PBS and symptoms of
BOO have been shown to overlap and exist together more
frequently than would be expected by chance in the Boston
Area Community Health Survey. This survey queried over
3,000 racially diverse community dwelling women and found
that 0.5% of the women reported pure symptoms of IC/PBS,
11.4% reported pure obstructive type symptoms, and 1.1%
reported both, making the overlap of symptoms more than
twice as prevalent as pure IC/PBS symptoms.20 A question-
naire sent to a sample of patients from Kaiser Permanente
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TABLE III. Mean Urinary Symptom Scores
Group Frequency score Urgency score Nocturia score SPP score Sum of scores
Non-ulcer PBS/IC 1.8 1.8 1.3 1.3 6.0
Ulcer PBSIIC 1.9 1.7 1.3 1.3 6.3
A/on-obstructed 1.7a 1.7 1.2 1.2 5.7a
Obstructed 1.9a 1.9 1.4 1.4 6.5a
Mann–Whitney test performed on all results.
SPP, suprapubic pain.
P < 0.05.
TABLE IV. Urodynamic Results
PBS/IC
P-value Non-obstructed Obstructed P-valueNon-ulcer Ulcer
Free flow maximum flow rate (ml/sec) 14.1 12.2 0.2 15.8 10.6 0.0006
Volume at first sensation (ml) 126.4 129.3 0.4 147.4 104.6 0.0007
MCC (ml) 269 200 0.006 298 214 <0.0001
Pdet at maximum flow (cm H2O) 33.3 37.4 0.1 23.1 45.8 <0.0001
Detrusor overactivity present 18.6% 13.2% 0.2 20.0% 15.5% 0.4
Qmax (ml/sec) 11.0 8.9 0.04 14.4 6.5 <0.0001
Residual Urine (ml) 77.4 56.2 0.2 58.2 91.0 0.006
Suprapubic pain on exam 70.6% 68.4% 0.3 69.9% 71.4% 0.9
BOO according to criteria 46.6% 55.2% 0.7 — — —
Ulcer PBS/IC — — — 18.9% 14.2% 0.4
PBS, painful bladder syndrome; IC, interstitial cystitis; MCC, maximum cystometric capacity; Pdet, detrusor pressure; Qmax, maximum flow; BOO, bladder
outlet obstruction.
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found similar overlap in symptoms of bladder pain, voiding
symptoms, and storage symptoms.21
BOO in women has, until recently, had no objective criteria
on uroflow or urodynamic studies. Several recent publications
have developed pressure-flow nomograms using data from
patients with anatomical obstruction, however there contin-
ues to be no universally accepted definition of BOO in
women.22 Our cut-off of Qmax 12 ml/sec and PdetQmax
25 cm H2O was based on the work of Defreitas and Zimmern
who studied UDPF in 169 women with clinically proven
anatomical obstruction compared to 20 female volunteer
without urologic symptoms or previous urologic surgery.6 We
deemed this to be the most accurate criteria since they
employed true asymptomatic controls to create their cut
points. Unfortunately, none of their cohort had functional
obstruction like those in our study, but all had a physical
obstruction, possibly reducing the generalizability of these
values to our population. These criteria were an extension of
this group’s previous work at developing a cut-point for BOO
in women. Their first proposed cut-off was a Qmax 15 ml/sec or
less and PdetQmax >20 cm H2O, but compared UDPF in women
with obstruction to those with stress urinary incontinence as
controls.4 Their second definition of obstruction was Qmax of
11 cm3/sec or less and PdetQmax >21 cm H2O in combination
with a clinical history and symptoms suggesting obstruction,
but these were again using women with stress incontinence
as the controls.23
Other authors have proposed various cut-points,5,8–10,24 but
in a comparison of five different diagnostic criteria to one
another,22 the cut-point chosen for our analysis was felt to
actually underestimate obstruction compared to fluoroscopic
urodynamics, and other criteria4 to greatly overestimated it.
Unfortunately, larger multi-center trials to validate these
values for an accepted definition of BOO in women are still
pending.
There are many limitations to our analysis. The NIDDK
research definition used to diagnose PBS/IC in this study are
very rigid and are designed for use in research, not clinical
practice. Many people with IC/PBS do not meet these
exhaustive criteria, but would be routinely diagnosed in a
clinical setting so there are many patients unnecessarily
excluded from this study.11
The urinary symptoms score, routinely employed in our
center at the time of the study, were essentially no different
between the ulcer and non-ulcer group, but was significantly
higher in the obstructed group compared to the non-
obstructed group. This was an unexpected finding since we
had hypothesized that the ulcer variant of the disease would
be more symptomatic due to their more severe disease.
However, this was not a validated questionnaire and their
results should be interpreted as such.
There were many difficulties with the urodynamic evalua-
tion of these women with PBS/IC. Twenty women were simply
unable to void during the study and were therefore excluded.
Ambulatory uroflows were done on all of these patients prior
to the urodynamics. However, only 122 of the women had a
large enough voided volumes (150 cm3) to be interpreted;
therefore we did not use these results in establishing the
diagnosis of BOO. Many would argue that free uroflows give a
more accurate assessment of obstruction than uroflowmetry
with a catheter during urodynamics.8,25
We do not have any fluoroscopic information on the
physical appearance of the bladder neck or outlet in these
studies to confirm the diagnosis of obstructive voiding. This
information would have been helpful in determining the
exact etiology of the obstruction.9,24
The number of women who met the obstruction criteria
that we selected pre-study was not different between the
ulcer and non-ulcer IC/PBS groups. We do not know, however,
if this would be different if we had chosen a different
urodynamics criteria for obstruction.
We had hoped that the EMG results would help to answer
the question of the etiology of the BOO being either a detrusor
contractility dysfunction, a learned behavior with poor pelvic
floor relaxation, or an actual outlet obstruction. We had
postulated that painful voiding was at the root of the problem
with pain causing a reflexive poor pelvic floor relaxation.
Unfortunately, the EMG data were not sufficient to make any
conclusions. However, we did see a higher bladder pressures
generated with the more severe ulcer IC/PBS with voiding
leading us to believe that these more severe cases of IC/PBS
have worse obstruction, not detrusor dysfunction.
Since PBS/IC is such a difficult disease to successfully treat,
most clinicians would welcome any further insight into better
management options. Given the likely functional cause of the
BOO seen in these women with PBS/IC supported by other
authors who have found significant pelvic floor dysfunction
in this group15 we suggest pelvic floor physical therapy,
biofeedback, muscle relaxants or alpha blockers as possible
non-invasive treatment regimens. These therapies have been
shown to be effective in functional external sphincter non-
relaxation.16,26,27 Another more invasive treatment modality
that is effective for female functional BOO and PBS/IC is sacral
neuromodulation26 and should be considered in refractory
cases.
In agreement with the International Consultation on IC
in Japan and the NIDDK12 we do not recommend routine
urodynamic investigation of women with PBS/IC since most
are treated clinically with little added information from
urodynamics. This cohort had UDF studies done prior to the
current recommendations and is a representative sample of
patients with PBS/IC in a tertiary care practice.
CONCLUSION
This study had confirmed our suspicions that some IC/PBS
patients do indeed have an element of obstructive voiding on
urodynamics. The etiology of the obstructed has still not been
elucidated, but is likely due to pelvic floor spasm secondary to
painful voiding. Future treatment strategies in women who
do have evidence of this obstruction could include alpha-1
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Fig. 1. Scatter plot of urodynamic detrusor pressure at maximum flow
(PdetQmax) and maximum flow rates (Qmax) of entire cohort. The values
corresponding with obstruction are in the yellow box.
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Urinary infection at time of urodynamics.
Patient unable to void during pressure-flow study.
Missing data.
Inclusion Criteria
Meet the NIDDK Diagnostic Criteria for IC1:11
To be diagnosed with IC, patients must have either
glomerulations on cystoscopic examination or classic Hun-
ner’s ulcer, and they must have either pain associated with the
bladder or urinary urgency. An examination for glomerula-
tions should be undertaken after distension of the bladder
with the patient under general anesthesia to 80–100 cm
water pressure for 1–2 min. The bladder may be distended up
to two times before evaluation. The glomerulations must be
diffuse, present in at least 3 quadrants of the bladder, and
there must be at least 10 glomerulations per quadrant. The
glomerulations must not be along the path of the cysto-
scope (to eliminate artefact from contact instrumentation).
The presence of any of the following criteria excludes the
diagnosis of IC:
(1) Bladder capacity greater than 350 cm3 on awake
cystometry using either a gas or liquid filling medium.
(2) Absence of an intense urge to void with the bladder filled
to 100 cm3 gas or 150 cm3 water during cystometry,
using a fill rate of 30–100 cm3/min.
(3) Duration of symptoms less than 9 months.
(4) Absence of nocturia.
(5) Symptoms relieved by antimicrobials, urinary antisep-
tics, anticholinergics, or antispasmodics.
(6) A frequency of urination, while awake of less than
eight times per day.
(7) A diagnosis of bacterial cystitis or prostatitis within a
3-month period.
(8) Bladder or ureteral calculi.
(9) Active genital herpes.
(10) Uterine, cervical, vaginal, or urethral cancer.
(11) Urethral diverticulum.
(12) Cyclophosphamide or any type of chemical cystitis.
(13) Tuberculous cystitis.
(14) Radiation cystitis.
(15) Benign or malignant bladder tumors.
(16) Vaginitis.
(17) Age less than 18 years.
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